The in vivo anti-tumor effect of human recombinant interleukin-6.
about
Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice.Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells.Antitumor effect of Bothrops jararaca venom.Subpopulations of mononuclear leukocytes associated with inhibition of Ehrlich ascites tumor growth by treatment with Bothrops jararaca venom.Expression of tumor necrosis factor-alpha and interleukin-6 in oral squamous cell carcinoma.
P2860
The in vivo anti-tumor effect of human recombinant interleukin-6.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
The in vivo anti-tumor effect of human recombinant interleukin-6.
@en
The in vivo anti-tumor effect of human recombinant interleukin-6.
@nl
type
label
The in vivo anti-tumor effect of human recombinant interleukin-6.
@en
The in vivo anti-tumor effect of human recombinant interleukin-6.
@nl
prefLabel
The in vivo anti-tumor effect of human recombinant interleukin-6.
@en
The in vivo anti-tumor effect of human recombinant interleukin-6.
@nl
P2093
P2860
P1476
The in vivo anti-tumor effect of human recombinant interleukin-6.
@en
P2093
P2860
P304
P356
10.1111/J.1349-7006.1990.TB03342.X
P577
1990-10-01T00:00:00Z